Rankings
▼
Calendar
AXGN Q2 2017 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena
AXGN
AxoGen, Inc.
$2B
Q2 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$15M
+46.1% YoY
Gross Profit
$13M
85.0% margin
Operating Income
-$1M
-9.5% margin
Net Income
-$2M
-13.6% margin
EPS (Diluted)
$-0.06
QoQ Revenue Growth
+23.9%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$724,377
Balance Sheet
Total Assets
$43M
Total Liabilities
$31M
Stockholders' Equity
$11M
Cash & Equivalents
$24M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$15M
$10M
+46.1%
Gross Profit
$13M
$9M
+45.7%
Operating Income
-$1M
-$2M
+10.0%
Net Income
-$2M
-$3M
+26.5%
← FY 2017
All Quarters
Q3 2017 →